Covid-19 vaccine trial in SA: all you need to know
Vaccines don’t always work equally well in all populations, and taking part in the trial at the start will help researchers to know early on whether South Africans could benefit from any vaccine that might come of this study
09 July 2020 - 06:00
How does the trial work?
The study we have embarked on in SA is for a vaccine that was developed by the Jenner Institute at the University of Oxford. It’s what is known as a nonreplicating vector based Covid-19 vaccine trial...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.